Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000094

Options or other derivatives

  • Director acquired 8,823 shares (grant or award)
  • Director returned 30,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Martell Bridget A · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-27 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −30,000 0 D
2024-02-28 Grant or award : show line 2 in the form Stock Option (Right to Buy) +8,823 8,823 D
Loading xslF345X05/form4.xml…